ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET ANALYSIS

Regional Analysis

Global Artificial Intelligence in Drug Discovery Market: Regional Insights

• Based on geography, the global artificial intelligence in drug discovery market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
• Among regions, North America is expected to gain highest share in the market during the forecast period due to the Strong economic growth and presence of well-equipped hospitals, research centers, universities, & medical device manufacturers are factors boosting the development of new products in this region. In addition, increasing need for managing & controlling overall costs & time associated with discovery & development of drugs, increasing cross-industry collaborations & partnerships, surge in the adoption of cloud-based services & applications, and impending patent expiry of blockbuster drugs are expected to further drive the market in North America. For instance, in May 2018, Intel announced its collaboration with Novartis for using deep neural networks to increase high-content screening to support early drug discovery 
• Europe and Asia Pacific are also expected to witness robust growth in the global artificial intelligence in drug discovery market owing to the Healthcare systems in Europe are overburdened due to increasing costs, growing incidence of chronic conditions, large elderly population, and increasing demand for healthcare facilities. In addition, increasing investments in AI in healthcare are expected to drive the market. For instance, in October 2019, the UK government announced an investment of USD 300 million in AI, which is expected to be utilized by the public healthcare system to improve quality of care. In 2018, General Data Protection Regulation (GDPR) outlined policies for personal data collection, processing, and security in healthcare organizations. This regulation divides heath data requiring special protection into three types: genetic data, biometric data, and data concerning health.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa